Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 586

1.

The strongly decentralized Swiss health system achieves good results: Past research has addressed persisting challenges - but more is encouraged.

Quentin W, Busse R.

Health Policy. 2018 Jun;122(6):565-567. doi: 10.1016/j.healthpol.2018.06.002. No abstract available.

PMID:
29935709
2.

Cross-country comparative research - Lessons from advancing health system and policy research on the occasion of the European Observatory on Health Systems and Policies' 20th anniversary.

Busse R, van Ginneken E.

Health Policy. 2018 May;122(5):453-456. doi: 10.1016/j.healthpol.2018.05.005. No abstract available.

PMID:
29861000
3.

Task shifting between physicians and nurses in acute care hospitals: cross-sectional study in nine countries.

Maier CB, Köppen J, Busse R; MUNROS team.

Hum Resour Health. 2018 May 25;16(1):24. doi: 10.1186/s12960-018-0285-9.

4.

Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe.

Fuchs S, Olberg B, Perleth M, Busse R, Panteli D.

Health Policy. 2018 Mar 14. pii: S0168-8510(18)30056-3. doi: 10.1016/j.healthpol.2018.03.004. [Epub ahead of print]

PMID:
29703653
5.

Paying hospital specialists: Experiences and lessons from eight high-income countries.

Quentin W, Geissler A, Wittenbecher F, Ballinger G, Berenson R, Bloor K, Forgione DA, Köpf P, Kroneman M, Serden L, Suarez R, van Manen JW, Busse R.

Health Policy. 2018 May;122(5):473-484. doi: 10.1016/j.healthpol.2018.03.005. Epub 2018 Mar 23.

6.

Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices.

Olberg B, Fuchs S, Panteli D, Perleth M, Busse R.

Value Health. 2017 Dec;20(10):1420-1426. doi: 10.1016/j.jval.2017.05.011. Epub 2017 Jun 20. Review.

PMID:
29241902
7.

Classification of hospital admissions into emergency and elective care: a machine learning approach.

Krämer J, Schreyögg J, Busse R.

Health Care Manag Sci. 2017 Nov 25. doi: 10.1007/s10729-017-9423-5. [Epub ahead of print]

PMID:
29177993
8.

How to strengthen financing mechanisms to promote care for people with multimorbidity in Europe? [Internet].

Struckmann V, Quentin W, Busse R, van Ginneken E; Richardson E, Van Ginneken E, editors.

Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2017.

9.

Evidence-based decision-making for diagnostic and therapeutic methods: the changing landscape of assessment approaches in Germany.

Olberg B, Fuchs S, Matthias K, Nolting A, Perleth M, Busse R.

Health Res Policy Syst. 2017 Oct 17;15(1):89. doi: 10.1186/s12961-017-0253-1.

10.

Relevant models and elements of integrated care for multi-morbidity: Results of a scoping review.

Struckmann V, Leijten FRM, van Ginneken E, Kraus M, Reiss M, Spranger A, Boland MRS, Czypionka T, Busse R, Rutten-van Mölken M; SELFIE consortium.

Health Policy. 2018 Jan;122(1):23-35. doi: 10.1016/j.healthpol.2017.08.008. Epub 2017 Oct 6.

11.

Hospital quality variation matters - A time-trend and cross-section analysis of outcomes in German hospitals from 2006 to 2014.

Pross C, Busse R, Geissler A.

Health Policy. 2017 Aug;121(8):842-852. doi: 10.1016/j.healthpol.2017.06.009. Epub 2017 Jul 8.

PMID:
28733067
12.

Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition.

Busse R, Blümel M, Knieps F, Bärnighausen T.

Lancet. 2017 Aug 26;390(10097):882-897. doi: 10.1016/S0140-6736(17)31280-1. Epub 2017 Jul 3. Review.

PMID:
28684025
13.

The SELFIE framework for integrated care for multi-morbidity: Development and description.

Leijten FRM, Struckmann V, van Ginneken E, Czypionka T, Kraus M, Reiss M, Tsiachristas A, Boland M, de Bont A, Bal R, Busse R, Mölken MR; SELFIE consortium.

Health Policy. 2018 Jan;122(1):12-22. doi: 10.1016/j.healthpol.2017.06.002. Epub 2017 Jun 20.

14.

Health system responsiveness and chronic disease care - What is the role of disease management programs? An analysis based on cross-sectional survey and administrative claims data.

Röttger J, Blümel M, Linder R, Busse R.

Soc Sci Med. 2017 Jul;185:54-62. doi: 10.1016/j.socscimed.2017.05.034. Epub 2017 May 17.

PMID:
28554159
15.

QUALITY OF SAMPLE SIZE ESTIMATION IN TRIALS OF MEDICAL DEVICES: HIGH-RISK DEVICES FOR NEUROLOGICAL CONDITIONS AS EXAMPLE.

Olberg B, Perleth M, Felgentraeger K, Schulz S, Busse R.

Int J Technol Assess Health Care. 2017 Jan;33(1):103-110. doi: 10.1017/S0266462317000265. Epub 2017 May 15.

PMID:
28502271
16.

Health care public reporting utilization - user clusters, web trails, and usage barriers on Germany's public reporting portal Weisse-Liste.de.

Pross C, Averdunk LH, Stjepanovic J, Busse R, Geissler A.

BMC Med Inform Decis Mak. 2017 Apr 21;17(1):48. doi: 10.1186/s12911-017-0440-6.

17.
18.

Measuring, Reporting, and Rewarding Quality of Care in 5 Nations: 5 Policy Levers to Enhance Hospital Quality Accountability.

Pross C, Geissler A, Busse R.

Milbank Q. 2017 Mar;95(1):136-183. doi: 10.1111/1468-0009.12248. No abstract available.

20.

Poland: A large but still under-researched country.

Busse R.

Health Policy. 2016 Nov;120(11):1217-1219. doi: 10.1016/j.healthpol.2016.11.008. No abstract available.

PMID:
27931739
21.

Pharmaceutical regulation in 15 European countries review.

Panteli D, Arickx F, Cleemput I, Dedet G, Eckhardt H, Fogarty E, Gerkens S, Henschke C, Hislop J, Jommi C, Kaitelidou D, Kawalec P, Keskimaki I, Kroneman M, Lopez Bastida J, Pita Barros P, Ramsberg J, Schneider P, Spillane S, Vogler S, Vuorenkoski L, Wallach Kildemoes H, Wouters O, Busse R.

Health Syst Transit. 2016 Oct;18(5):1-122. Review.

22.

Pay-for-performance: Time to act but also to provide further evidence.

Busse R.

Health Policy. 2016 Oct;120(10):1123-1124. doi: 10.1016/j.healthpol.2016.10.001. No abstract available.

PMID:
27816089
23.

Assessing the benefit of new pharmaceuticals: Are we talking the same language, can we explain disagreement, and would it be better to do it together?

Busse R.

Health Policy. 2016 Oct;120(10):1101-1103. doi: 10.1016/j.healthpol.2016.10.006. No abstract available.

PMID:
27816088
24.

Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage.

Maier B, Wagner K, Behrens S, Bruch L, Busse R, Schmidt D, Schühlen H, Thieme R, Theres H.

BMC Health Serv Res. 2016 Oct 21;16(1):605.

25.

HTA of medical devices: Challenges and ideas for the future from a European perspective.

Fuchs S, Olberg B, Panteli D, Perleth M, Busse R.

Health Policy. 2017 Mar;121(3):215-229. doi: 10.1016/j.healthpol.2016.08.010. Epub 2016 Sep 14.

PMID:
27751533
26.

HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES IN EUROPE: PROCESSES, PRACTICES, AND METHODS.

Fuchs S, Olberg B, Panteli D, Busse R.

Int J Technol Assess Health Care. 2016 Jan;32(4):246-255. Epub 2016 Sep 27.

PMID:
27670589
27.

Descriptive, cross-country analysis of the nurse practitioner workforce in six countries: size, growth, physician substitution potential.

Maier CB, Barnes H, Aiken LH, Busse R.

BMJ Open. 2016 Sep 6;6(9):e011901. doi: 10.1136/bmjopen-2016-011901. Erratum in: BMJ Open. 2016;6(9):e011901corr1.

28.

Evaluating the Impact of an Accountable Care Organization on Population Health: The Quasi-Experimental Design of the German Gesundes Kinzigtal.

Pimperl A, Schulte T, Mühlbacher A, Rosenmöller M, Busse R, Groene O, Rodriguez HP, Hildebrandt H.

Popul Health Manag. 2017 Jun;20(3):239-248. doi: 10.1089/pop.2016.0036. Epub 2016 Aug 26.

PMID:
27565005
29.

Canada: Focus on a country's health system with provincial diversity.

Sutherland JM, Busse R.

Health Policy. 2016 Jul;120(7):729-31. doi: 10.1016/j.healthpol.2016.06.010. No abstract available.

PMID:
27381071
30.

South Korea: An interesting case to study.

Kwon S, Busse R.

Health Policy. 2016 Jun;120(6):577-9. doi: 10.1016/j.healthpol.2016.06.002. No abstract available.

PMID:
27321546
31.

The iMpact on practice, oUtcomes and costs of New roles for health pROfeSsionals: a study protocol for MUNROS.

Bond C, Bruhn H, de Bont A, van Exel J, Busse R, Sutton M, Elliott R; MUNROS team.

BMJ Open. 2016 Apr 26;6(4):e010511. doi: 10.1136/bmjopen-2015-010511.

32.

How do Chronically Ill Patients Rate Medical Care by their GPs and Specialists? Results of a Germany-wide Survey.

Röttger J, Busse R.

Gesundheitswesen. 2016 Sep;78(S 01):e89-e96. Epub 2016 Feb 16.

33.

Health-care improvements in a financially constrained environment.

Ekman I, Busse R, van Ginneken E, Van Hoof C, van Ittersum L, Klink A, Kremer JA, Miraldo M, Olauson A, De Raedt W, Rosen-Zvi M, Strammiello V, Törnell J, Swedberg K.

Lancet. 2016 Feb 13;387(10019):646-7. doi: 10.1016/S0140-6736(16)00285-3. No abstract available.

34.

The policy contribution of the German Health Economic Centres.

Sundmacher L, Busse R.

Health Policy. 2016 Feb;120(2):139-40. doi: 10.1016/j.healthpol.2016.01.019. Epub 2016 Jan 28. No abstract available.

PMID:
26851990
35.

Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward.

Panteli D, Nolting A, Eckhardt H, Kulig M, Busse R.

Health Res Policy Syst. 2016 Jan 26;14:6. doi: 10.1186/s12961-016-0080-9.

36.

Forgone care among chronically ill patients in Germany-Results from a cross-sectional survey with 15,565 individuals.

Röttger J, Blümel M, Köppen J, Busse R.

Health Policy. 2016 Feb;120(2):170-8. doi: 10.1016/j.healthpol.2016.01.004. Epub 2016 Jan 11.

PMID:
26806678
37.

TAXONOMY OF MEDICAL DEVICES IN THE LOGIC OF HEALTH TECHNOLOGY ASSESSMENT.

Henschke C, Panteli D, Perleth M, Busse R.

Int J Technol Assess Health Care. 2015 Jan;31(5):324-30. doi: 10.1017/S0266462315000562. Epub 2015 Dec 29.

PMID:
26711471
38.

CONSIDERING EQUITY IN HEALTH TECHNOLOGY ASSESSMENT: AN EXPLORATORY ANALYSIS OF AGENCY PRACTICES.

Panteli D, Kreis J, Busse R.

Int J Technol Assess Health Care. 2015 Jan;31(5):314-23. doi: 10.1017/S0266462315000549. Epub 2015 Dec 29.

PMID:
26711222
39.

Analyzing Protein-Phosphoinositide Interactions with Liposome Flotation Assays.

Busse RA, Scacioc A, Schalk AM, Krick R, Thumm M, Kühnel K.

Methods Mol Biol. 2016;1376:155-62. doi: 10.1007/978-1-4939-3170-5_13.

PMID:
26552682
40.

From market access to patient access: overview of evidence-based approaches for the reimbursement and pricing of pharmaceuticals in 36 European countries.

Panteli D, Eckhardt H, Nolting A, Busse R, Kulig M.

Health Res Policy Syst. 2015 Sep 25;13:39. doi: 10.1186/s12961-015-0028-5.

41.

Deciding when physicians are unfit to practise: an analysis of responsibilities, policy and practice in 11 European Union member states.

Struckmann V, Panteli D, Legido-Quigley H, Risso-Gill I, McKee M, Busse R.

Clin Med (Lond). 2015 Aug;15(4):319-24. doi: 10.7861/clinmedicine.15-4-319.

PMID:
26407378
42.

Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.

Röttger J, Blümel M, Engel S, Grenz-Farenholtz B, Fuchs S, Linder R, Verheyen F, Busse R.

Int J Health Policy Manag. 2015 May 20;4(7):431-7. doi: 10.15171/ijhpm.2015.97.

43.

[Erratum to: Teleradiological report turnaround times. An internal efficiency and quality control analysis].

Seithe T, Busse R, Rief M, Doyscher R, Albrecht L, Rathke H, Jonczyk M, Poschmann R, Tepe H, Hamm B, de Bucourt M.

Radiologe. 2015 Jun;55(6):497. doi: 10.1007/s00117-015-2864-2. German. No abstract available.

PMID:
26081675
44.

[Hemodiafiltration compared to hemodialysis regarding all-cause mortality and quality of life: a systematic review].

Panteli D, Wittenbecher F, Busse R.

Dtsch Med Wochenschr. 2015 May;140(11):e114-9. doi: 10.1055/s-0041-102110. Epub 2015 May 28. Review. German.

PMID:
26080729
45.

Characterization of PROPPIN-Phosphoinositide Binding and Role of Loop 6CD in PROPPIN-Membrane Binding.

Busse RA, Scacioc A, Krick R, Pérez-Lara Á, Thumm M, Kühnel K.

Biophys J. 2015 May 5;108(9):2223-34. doi: 10.1016/j.bpj.2015.03.045.

46.

[Teleradiological report turnaround times: An internal efficiency and quality control analysis].

Seithe T, de Bucourt M, Busse R, Rief M, Doyscher R, Albrecht L, Rathke H, Jonczyk M, Poschmann R, Tepe H, Hamm B.

Radiologe. 2015 May;55(5):409-16. doi: 10.1007/s00117-015-2858-0. German. Erratum in: Radiologe. 2015 Jun;55(6):497.

PMID:
25944276
48.

Costs and effects of new professional roles: Evidence from a literature review.

Tsiachristas A, Wallenburg I, Bond CM, Elliot RF, Busse R, van Exel J, Rutten-van Mölken MP, de Bont A; MUNROS team.

Health Policy. 2015 Sep;119(9):1176-87. doi: 10.1016/j.healthpol.2015.04.001. Epub 2015 Apr 13. Review.

PMID:
25899880
49.

Informed consumer or unlucky visitor? A profile of German patients who received dental services abroad.

Panteli D, Augustin U, Röttger J, Struckmann V, Verheyen F, Wagner C, Busse R.

Community Dent Oral Epidemiol. 2015 Oct;43(5):415-23. doi: 10.1111/cdoe.12164. Epub 2015 Apr 21.

PMID:
25899852
50.

'Know before you go': information-seeking behaviour of German patients receiving health services abroad in light of the provisions of Directive 2011/24/EU.

Panteli D, Wagner C, Verheyen F, Busse R.

J Health Serv Res Policy. 2015 Jul;20(3):154-61. doi: 10.1177/1355819615580003. Epub 2015 Apr 20.

PMID:
25899483

Supplemental Content

Support Center